問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of General Internal Medicine

Division of Neurology

Division of Cardiovascular Diseases

更新時間:2025-03-14

莊志明JUANG, JYH-MING JIMMY
  • Principal Investigator
  • Clinical Trial Experience (year) 17 years 9 個月
  • juang.ntuhcvgenetext@gmail.com

  • juang.ntuhcvgenetext@gmail.com

Publication

131Publications

81

Lin JF, Wu S, Juang JJ, Chiang FT, Hsu LA, Teng MS, Cheng ST, Huang HL, Ko YL. Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases.Biomark Med. 2019 Jun;13(9):751-760. doi: 10.2217/bmm-2018-0458. Epub 2019 Jun 3.PMID: 31157557

82

Chiang JY, Lee SH, Chen YC, Wu CK, Chuang JY, Lo SC, Yeh HM, Yeh SS, Hsu CA, Lin BB, Chang PC, Chang CH, Liang HJ, Chiang FT, Lin CY, Juang JJ* (co-correspondent). Metabolomic Analysis of Platelets of Patients With Aspirin Non-Response. Front Pharmacol. 2019 Oct 10;10:1107. doi: 10.3389/fphar.2019.01107. eCollection 2019

83

Huang HL, Juang JJ, Hsieh CA, Chou HH, Jang SJ, Ko YL. Risk stratification for low extremity amputation in critical limb ischemia patients who have undergone endovascular revascularization: A survival tree analysis. Medicine (Baltimore). 2019 Aug;98(33):e16809. doi: 10.1097/MD.0000000000016809.

84

Lin TT, Wang YC, Juang JJ, Hwang JJ, Wu CK. Application of the newest European Association of Cardiovascular Imaging Recommendation regarding the long-term prognostic relevance of left ventricular diastolic function in heart failure with preserved ejection fraction.Eur Radiol. 2019 Aug 8. doi: 10.1007/s00330-019-06261-1. [Epub ahead of print] 2020出版

85

Julio Rosenstock, MD1,2; Vlado Perkovic, MBBS, PhD3; Odd Erik Johansen, MD, PhD4; Jyh-Ming Juang, et al Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk The CARMELINA Randomized Clinical Trial. JAMA. 2019;321(1):69-79. doi:10.1001/jama.2018.18269

86

McGuire, DK (McGuire, Darren K.)[ 1 ] ; Alexander, JH (Alexander, John H.)[ 2 ] ; Johansen, OE (Johansen, Odd Erik)[ 3 ] ; Perkovic, V (Perkovic, Vlado)[ 4 ] ; Rosenstock, J (Rosenstock, Julio)[ 5 ] ; Cooper, ME (Cooper, Mark E.)[ 6 ] ; Wanner, C (Wanner, Christoph)[ 7 ] ; Kahn, SE (Kahn, Steven E.)[ 8,9 ] ; Toto, RD (Toto, Robert D.)[ 1 ] ; Zinman, B (Zinman, Bernard), Jyh-Ming Juang, et. A.. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. Circulation. 2019;139:351–361. DOI: 10.1161/CIRCULATIONAHA.118.038352

87

MacDonald MR1, Tay WT2, Teng TK2,3, Anand I4, Ling LH5, Yap J2, Tromp J2,6, Wander GS7, Naik A8, Ngarmukos T9, Siswanto BB10, Hung CL11, Richards AM5,12, Lam CSP2,6,13; ASIAN‐F investigators †. Liew HB, Narasimhan C, Park SW, Reyes E, Shimizu W, Zhang S, Wu L, Ling T, Li X, Zhang H, Su Y, Yu CM, Sastry BKS, Gopi A, Raghu K, Sridevi C, Kaur D, Parikh K, Chandarana A, Shah U, Chag M, Baxi H, Gupta S, Bhatia J, Khakhkhar V, Sankhla V, Patel T, Kapoor V, Tandon R, Chopra V, Kumar M, Sethi HJS, Verma R, Sawhney J, Sharma MK, Purayil MP, Munawar M, Pambudi JA, Lukito A, Pardede I, Thengker A, Damay V, Danny SS, Surarso R, Yasuoka R, Asai K, Ikeda T, Park SW, Hong SK, Lee S, Soo LD, Kim DH, Shim J, Park SM, Roh SY, Kim YH, Kim M, Choi JI, Na JO, Rha SW, Seo HS, Oh DJ, Park CG, Kim EJ, Lee S, Joung B, Uhm JS, Lee MH, Cho IJ, Park HN, Park HW, Cho JG, Yoon N, Lee K, Kim KH, Kim SH, Liew HB, Saharudin S, Beh BC, Lee YW, Yen CH, Othman MK, Augustine AA, Asnawi MHM, Mojolou RA, Tan YZ, Arbain AN, Wong CK, Ghazi AM, Khelae SK, Chew DSP, Yap LB, Hussin A, Muhammad Z, Abidin IZ, Zhudi ASBM, Sari NAM, Sridhar GS, Zuhdi ASM, Ismail MD, Ong TK, Cham YL, Khiew NZ, Said AB, Fong AYY, Amin NHM, Seng KC, Tan SK, Yew KL, Reyes E, Santos J, Lim A, Lapitan R, Andal R, Lopez E, Sim KLD, Tan BY, Lim CP, Teo LLY, Chan LLH, Chai P, Wong CCR, Poh KK, Yeo PSD, Lee EM, Loh SY, Ching ME, Khoo DZL, Yew MS, Huang W, See JHJ, Lim YB, Tan S, Yeo C, Chai SC, Jaufeerally FR, Tulsidas H, Aung T, Ong HY, Ling LF, Soon DKN, Yeh HI, Kuo JY, Yen CH, Hwang JJ, Chien KL, Su TC, Lin LY, Juang JM, Lin YH, Chiang FT, Lin JL, Ho YL, Lee CM, Lin PC, Hung CS, Chang SN, Lin JW, Hsu CN, Yu WC, Chao TF, Sung SH, Wang KL, Leu HB, Lin YJ, Chang SL, Huang PH, Lo LW, Wu CH, Liang HY, Chang SS, Hsiao LC, Wang YC, Lu CR, Wu HP, Lin YN, Chen KW, Lo PH, Hsu CH, Hsieh LC, Chandavimol M, Yingchoncharoen T, Laothavorn P, Wongcharoen W, Phrommintikul A. Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry. J Am Heart Assoc. 2020 Jan 7;9(1):e012199. doi: 10.1161/JAHA.119.012199. Epub 2019 Dec 19.

88

Chen, JF Chen, HS Chu, CH Chuang, LM Ho, LT Hung, YJ Kuo, CH Li, HY Lin, CH Lin, KD Lin, SY Sheen, YJ Sheu, WHH Shin, SJ Tsai, ST Te Tu, S Bai, CH Chang, YC Chang, TJ Chang, CH Chang, CJ Chao, CC Chen, CC Chen, YL Chong, K Chuang, WL Guo, LY Hsieh, MC Hsu, CC Huang, LC Huang, CN Huang, YY Hung, CS Hung, WW Hwu, CM Jeng, JS Jiang, YD Juang, JMJ Juang, JH Kuo, CS Kuo, JF Kwok, CF Lai, YC Lee, MY Lee, YJ Lee, IT Lee, CN Lee, YT Lee, TI Lee, CH Lin, LY Lin, SD Lin, KY Lin, HJ Lin, CH Liu, CE Lo, FS Lu, CH Lu, KC Ma, WY Ou, HY Pei, D Su, CC Su, SL Tan, ECH Tien, KJ Tsai, LK Tseng, CH Wang, JS Weng, SF Wu, WC Yang, MC Yang, YS Yang, CH Yang, WS Yeh, JT Yu, NC Yu, TY. Executive summary of the DAROC clinical practice guidelines for diabetes care-2018 Diabetes Association of the Republic of China (Taiwan). J FORMOS MED ASSOC. 2020 Feb;119(2):577-586. doi: 10.1016/j.jfma.2019.02.016. Epub 2019 Apr 3.

89

Sherri Shih-Fan Yeh 1, Ching-Yu Julius Chen 2, I-Chien Wu 3, Chih-Cheng Hsu 3, Tzu-Yu Chen 3, Wei-Ting Tseng 3, Feng-Cheng Tang 4, Chi-Chung Wang 5, Chung-Chou Juan 6, Hou-Chang Chiu 7 8, Huey-Ming Lo 9 10, Dun-Hui Yang 11, Jyh-Ming Jimmy Juang (Correspondent Author) *2, Chao Agnes Hsiung Prognostic value and prevalence of complete right bundle branch block in an elderly population: a community-based 10-year prospective study. Aging-US. 2020 Oct 6;12(19):19073-19082. doi: 10.18632/aging.103702.

90

Juang JJ, Binda A, Lee SJ, Hwang JJ, Chen WJ, Liu YB, Lin LY, Yu CC, Ho LT, Huang HC, Chen CJ, Lu TP, Lai LC, Yeh SS, Lai LP, Chuang EY, Rivolta I, Antzelevitch C. GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death. EBioMedicine. 2020 Jul;57:102843. doi: 10.1016/j.ebiom.2020.102843. Epub 2020 Jul 7.